Droloxifenum
Droloxifenum Uses, Dosage, Side Effects, Food Interaction and all others data.
Droloxifenum, a derivative of the triphenylethylene drug tamoxifen, is a novel selective estrogen receptor modulator (SERM). Droloxifenum also exhibits more rapid pharmacokinetics, reaching peak concentrations and being eliminated much more rapidly than tamoxifen. Its higher affinity to the estrogen receptor, higher anti-estrogenic to estrogenic ratio, more effective inhibition of cell growth and division in estrogen receptor-positive cell lines, and lower toxicity give it theoretical advantages over tamoxifen in the treatment of human breast cancer. Short-term toxicity was generally mild, and similar to that seen with other antiestrogens. Droloxifenum appears active and tolerable. It may have a particular role in situations in which rapid pharmacokinetics, or an increased antiestrogenic to estrogenic ratio, are required. Droloxifenum may also be a potentially useful agent for the treatment of postmenopausal osteoporosis because it can prevent estrogen deficiency-induced bone loss without causing uterine hypertrophy. Droloxifenum may have an effect on bone and breast tissue because it induces apoptosis. Droloxifenum has an anti-implantation effect in rats, and the effect appears to be not completely due to its anti-estrogenic activity.
| Trade Name | Droloxifenum |
| Generic | Droloxifene |
| Droloxifene Other Names | Droloxifene, Droloxifeno, Droloxifenum |
| Type | |
| Formula | C26H29NO2 |
| Weight | Average: 387.523 Monoisotopic: 387.219829178 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Droloxifenum
